| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $237K | +0.0% |
| R&D Expense | $12K | -92.4% |
| SG&A Expense | $75K | — |
| Operating Income | -$339K | +19.0% |
| Pre-tax Income | -$1.3M | -90.7% |
| Income Tax | $0 | — |
| Net Income | -$1.3M | -47.0% |
| EPS (Basic) | -$0.05 | +76.2% |
| EPS (Diluted) | -$0.05 |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70K | +9614.4% |
| Accounts Receivable | $205K | +115.9% |
| Current Assets | $275K | +71.8% |
| Total Assets | $275K | +54.6% |
| Current Liabilities | $6.6M | +22.0% |
| Total Liabilities | $6.6M | +22.0% |
| Stockholders' Equity | -$6.3M | -20.9% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$384K | +44.7% |
| Financing Cash Flow | $452K | -21.0% |
| +76.2% |